Christopher Robinson: Early Pregnancy Oxylipins May Signal Risk of Fetal Growth Restriction
Christopher Robinson, Physician, Partner at Charleston Maternal Fetal Medicin, shared a post on LinkedIn about a recent article by Kelly Ferguson et al, published in American Journal of Obstetrics Gynecology, adding:
“Early pregnancy oxylipin markers of inflammation and oxidative stress are associated with small-for-gestational-age birth and specific phenotypes of fetal growth restriction – Pathways of oxylipin production and obstetric relevance.”
Title: Early pregnancy oxylipin markers of inflammation and oxidative stress are associated with small-for-gestational-age birth and specific phenotypes of fetal growth restriction
Authors: Kelly K. Ferguson, Barrett M. Welch, Danielle R. Stevens, Paige A. Bommarito, Ginger L. Milne, John D. Meeker, Matthew L. Edin, Darryl C. Zeldin, David E. Cantonwine, Thomas F. McElrath
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 27, 2026, 16:28Rose Agor: Celebrating Two New Publications in Haematology Research
-
Oct 27, 2026, 16:21Pregnancy and Thrombosis-What Clinicians Need to Know – World Thrombosis Day
-
Oct 27, 2026, 16:13Lesley Van Wyk: DIC vs TTP vs HUS – The Key Diagnostic Clues
-
Oct 27, 2026, 16:02Ahmad G. Alzahrani: AF and Vascular Risk Factors – Should We Add Antiplatelet Therapy?
-
Oct 27, 2026, 16:02Iron Deficiency and Thrombocytosis: How Iron Availability Shapes Hematopoietic Lineage Decisions
-
Oct 27, 2026, 15:46Christiane Berger-Schaffitzel: New PhD Project Explores Snake Venom and Haemostasis
-
Oct 27, 2026, 13:51Muhammed Hajmusa: ESMO 2026 Highlights the Challenge of Anticoagulation in ROS1-Positive Lung Cancer
-
Oct 27, 2026, 13:39Luca Galassi: Retrieved Venous Thrombi as a Tool for Predicting Post-Thrombotic Syndrome
-
Oct 27, 2026, 11:43Tareq Abadl: Hidden Interferences Behind Unexpected Laboratory Results